EDIT
Editas Medicine
Rating 2.5 / 5 Recommendation Pass

Credit put spread analysis · · Moderate setup

IV Rank
100
Implied volatility percentile
Trend
0.32
Long-term trend score
Safety
5/9
Quality checks passed
Drop
-8.1%
Day 2 of drop
Reversal
Bullish Engulfing
Day 5
1Y Change
30.6%
Trailing 12 months
Earnings
Clear
No event in window

AI analysis

Stock at $2. 60 is extremely low-priced, making a standard credit put spread impractical. The 30.

6% 2-month gain and bullish engulfing signal are positive, but the -8. 07% drop yesterday and 100% IV indicate high volatility and risk. The primary issue is strike availability and premium quality.

To meet the 3-7% OTM rule, the sell strike would be around $2. 47-$2. 42.

The next lower strike is likely $2. 00 or $2. 50, depending on the chain.

A $0. 50 spread width ($2. 50/$2.

00) would be 19% of the stock price, violating the 5-10% width guidance. The estimated credit on such a spread would be minimal, likely under $0. 10, failing the critical credit/width >= 0.

25 rule (e. g. , $0.

10/$0. 50 = 0. 20).

Even if a $0. 25 width existed ($2. 50/$2.

25), the premium would be too low to justify the risk. The low safety score (5/9) and penny-stock nature amplify the risk of a sharp decline breaching the short put. While there's a bullish reversal signal, the structural constraints for a profitable, rule-compliant spread are absent.

Better opportunities exist with higher-priced stocks where we can construct a proper spread with adequate premium.

Earlier analyses

  1. 2.5/5 Pass

    Stock is at $2.46 with 100% IV, indicating high premium, but the underlying fundamentals are extremely poor. A Safety score of 5/9 is a major red flag for a credit put spread, which relies on the stock not collapsing. Th…

  2. 1.5/5 Pass

    Recommendation: PASS. The stock's extremely low price of $2.53 presents significant challenges for structuring a viable credit put spread. The primary issue is the bid-ask spread and liquidity for options on such a low-p…

  3. 1.2/5 Pass

    PASS. The stock at $2.62 is a micro-cap, penny-stock territory with a 'Safety' score of 4/9, indicating high fundamental risk. While the 100% IV suggests premium is available, constructing a viable credit put spread is n…

  4. 2.5/5 Pass

    The stock's profile presents a high-risk, low-reward scenario unsuitable for a credit put spread. While the Bullish Engulfing pattern and recent uptrend offer a glimmer of hope, the critical metrics are overwhelmingly ne…

  5. 2.5/5 Pass

    Analyzing the stock at $2.90, which dropped -7.84% yesterday. While the drop creates a potential entry for a credit put spread, several critical factors argue against opening a position. The stock price is extremely low,…